A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Clinical trial NCT05672524 · RECRUITING

Trial details

NCT number: NCT05672524
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Rectum Locally Advanced Rectal Adenocarcinoma Rectal Adenocarcinoma HER2 Positive Rectal Adenocarcinoma Rectal Cancer

Start date: 2022-12-30
Primary completion: 2027-07-30
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.